Tom Spencer

JANUARY 31, 2025

In recent years, there have been large M&A deals involving pharmaceutical and biotechnology companies, and a significant area of expansion in the technology space – health tech. The global life sciences consulting market is expected to grow by around 10% per year from 2024 to 2029. What is life sciences consulting?

Biotechnology 88

Biotechnology Healthcare Pharmaceuticals Consulting 88

Harvard Business

JANUARY 11, 2017

Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. Remaining efficient and productive overtook deeper reflection on the ethical implications of “selling” products to customers without their knowledge.

Ethics 70

Ethics Training Training Exercises 70

Harvard Business

JUNE 16, 2016

The private sector spends three times that , mostly on translational research intended to transform basic discoveries into new products. There is a wide chasm that separates an initial discovery and a viable product idea. Yet the Valley of Death still remains. Innovating the Innovation Process. Killing Ideas Faster.

Government 70

Government Research Journal Biotechnology 70

Tom Spencer

JANUARY 17, 2025

As we stand on the cusp of a political shift in the United States, the intersection of biotechnology, regulatory policy, and healthcare is poised for profound transformation. While there is no explicit move to sever ties with foreign partners, the tone suggests a preference for domestic production and innovation.

Policies 88

Policies Healthcare Biotechnology Industry 88